학술논문
352 Target modulation within the tumor microenvironment (TME) by daratumumab (anti-CD38) but not edicotinib (CSF-1R inhibitor) in men with high-risk localized prostate cancer
Document Type
article
Author
Source
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Subject
Language
English
ISSN
2051-1426